Hims & Hers Launch Two New Hair Loss Prevention Products

1 min read

Hims & Hers, the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, has launched two new prescription offerings — Topical Finasteride & Minoxidil Spray and Oral Spironolactone — to provide women with more effective solutions to address hair loss, which 1 in 3 women — roughly 30 million women in the US alone — experience at some time in their lives.

“This launch is the direct result of Hers’ close relationship with our consumers, listening to their health goals and what they feel is missing from the hair loss market,” said Hilary Coles, co-founder and SVP of Brand & Innovation, Hims & Hers. “Our ability to continue to bring clinically-proven ingredients to market in a unique dosage form through innovative compounding preparations remains unparalleled. We’ve made it our mission to destigmatize issues like hair loss so that women aren’t embarrassed to confidently take control of their health!”

To continue reading this article, create a free account or Login